(lp0
S"Synergy's Trulance Looking Like The Next Uceris Seeking Alpha - Mar 13, 2017 Synergy Pharmaceuticals , a gastrointestinal company out of New York, was recently approved for their drug Trulance.Synergy Pharmaceuticals: Approval, Now What? - Bloomington Pantagraph"
p1
aS"Synergy Pharmaceuticals to Present at Oppenheimer 27th Annual Healthcare ... Yahoo Finance - Mar 14, 2017 Synergy Pharmaceuticals Inc.  today announced that Marino Garcia, the company's EVP and Chief Strategy Officer, will present a corporate update at the Oppenheimer 27th Annual Healthcare Conference on Tuesday, March 21, 2017 at 11:30 a.m.&nbsp;..."
p2
aS"Canaccord Chimes in on Synergy Pharmaceuticals Inc  as It Prepares for ... Smarter Analyst - Mar 2, 2017 Yesterday, Synergy Pharmaceuticals Inc  reported fourth-quarter financial results and reiterated the launch of Trulance , Synergy's recently-approved lead drug, for treatment of chronic idiopathic constipation , which is&nbsp;...CORRECTING and REPLACING Synergy Pharmaceuticals Reports Fourth Quarter and ... - Yahoo FinanceSynergy Pharmaceuticals Inc.  Soars 7.83% on February 27 - Equities.com"
p3
aS"What are Analyst's Indicators for Synergy Pharmaceuticals Inc. , Range ... The USA Commerce - 19 hours ago Shares of Synergy Pharmaceuticals Inc.  dropped -2.84% to $5.14. During the trading on 03/14/2017, Company's stock ranged from $5.13 to $5.35.The Synergy Pharmaceuticals Inc  Short Interest Update - Petro Global News 24Synergy Pharmaceuticals Inc.  Files An 8-K Other Events - Market Exclusive"
p4
aS"Traders Secrets on Synergy Pharmaceuticals Inc. , Glu Mobile Inc.  StockNewsJournal - Mar 14, 2017 Synergy Pharmaceuticals Inc. , maintained return on investment for the last twelve months at -253.37, higher than what Reuters data shows regarding industry's average."
p5
aS'Why to Keeping Eye on Synergy Pharmaceuticals Inc. , Global Blood ... StockNewsJournal - Mar 10, 2017 ROI deals with the invested cash in the company and the return the investor realize on that money based on the net profit of the business.'
p6
aS'Synergy: 3 Scenarios, 1 Choice Seeking Alpha - Feb 24, 2017 Synergy Pharmaceuticals  is a biopharmaceutical company focused on the treatment of gastrointestinal diseases and disorders.'
p7
aS'Synergy Pharmaceuticals Inc. : Ignore the noise and focus on the technicals USA Commerce Daily - Mar 14, 2017 With all other things going on, Synergy Pharmaceuticals Inc.  has been on a free fall - declining -4.51 percent in just three months.'
p8
aS"Levels in Focus on Shares of Synergy Pharmaceuticals Inc.  Rives Journal - Mar 13, 2017 Market watchers might be keeping an eye on Synergy Pharmaceuticals Inc. 's Piotroski F-Score. The F-Score was created to help spot company stocks that have solid fundamentals, and to filter out weaker companies."
p9
aS'Price Index Watch on Shares of Synergy Pharmaceuticals Inc.  Davidson Register - 17 hours ago Active investors may be taking a second look at shares of Synergy Pharmaceuticals Inc. . Checking in on some levels, the six month price index is currently at 0.88165.'
p10
a.